Your browser doesn't support javascript.
loading
Clinical and genetic characterization of leukoencephalopathies in adults.
Lynch, David S; Rodrigues Brandão de Paiva, Anderson; Zhang, Wei Jia; Bugiardini, Enrico; Freua, Fernando; Tavares Lucato, Leandro; Macedo-Souza, Lucia Inês; Lakshmanan, Rahul; Kinsella, Justin A; Merwick, Aine; Rossor, Alexander M; Bajaj, Nin; Herron, Brian; McMonagle, Paul; Morrison, Patrick J; Hughes, Deborah; Pittman, Alan; Laurà, Matilde; Reilly, Mary M; Warren, Jason D; Mummery, Catherine J; Schott, Jonathan M; Adams, Matthew; Fox, Nick C; Murphy, Elaine; Davagnanam, Indran; Kok, Fernando; Chataway, Jeremy; Houlden, Henry.
Afiliação
  • Lynch DS; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Rodrigues Brandão de Paiva A; Leonard Wolfson Experimental Neurology Centre, UCL Institute of Neurology, London, UK.
  • Zhang WJ; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Bugiardini E; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Freua F; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
  • Tavares Lucato L; Neurogenetics Unit, Neurology Department, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Macedo-Souza LI; Instituto de Radiologia, Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Lakshmanan R; Centro de Estudos do Genoma Humano, Universidade de São Paulo, São Paulo, Brazil.
  • Kinsella JA; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Merwick A; Neurology Department, St. Vincent's University Hospital and University College Dublin, Ireland.
  • Rossor AM; Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Bajaj N; Chelsea and Westminster NHS Foundation Trust, London, UK.
  • Herron B; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
  • McMonagle P; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, UK.
  • Morrison PJ; Department of Neurology, Queens Medical Centre, Nottingham, UK.
  • Hughes D; Department of Neuropathology, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
  • Pittman A; Department of Neurology, Royal Victoria Hospital, Belfast, Northern Ireland, UK.
  • Laurà M; Centre for Cancer Research and Cell Biology, Queens University of Belfast, 97 Lisburn Road, Belfast BT9 7AE, UK.
  • Reilly MM; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Warren JD; Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK.
  • Mummery CJ; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
  • Schott JM; MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
  • Adams M; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Fox NC; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Murphy E; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Davagnanam I; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Kok F; Dementia Research Centre, UCL Institute of Neurology, London, UK.
  • Chataway J; Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Houlden H; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Brain ; 140(5): 1204-1211, 2017 May 01.
Article em En | MEDLINE | ID: mdl-28334938
Leukodystrophies and genetic leukoencephalopathies are a rare group of disorders leading to progressive degeneration of cerebral white matter. They are associated with a spectrum of clinical phenotypes dominated by dementia, psychiatric changes, movement disorders and upper motor neuron signs. Mutations in at least 60 genes can lead to leukoencephalopathy with often overlapping clinical and radiological presentations. For these reasons, patients with genetic leukoencephalopathies often endure a long diagnostic odyssey before receiving a definitive diagnosis or may receive no diagnosis at all. In this study, we used focused and whole exome sequencing to evaluate a cohort of undiagnosed adult patients referred to a specialist leukoencephalopathy service. In total, 100 patients were evaluated using focused exome sequencing of 6100 genes. We detected pathogenic or likely pathogenic variants in 26 cases. The most frequently mutated genes were NOTCH3, EIF2B5, AARS2 and CSF1R. We then carried out whole exome sequencing on the remaining negative cases including four family trios, but could not identify any further potentially disease-causing mutations, confirming the equivalence of focused and whole exome sequencing in the diagnosis of genetic leukoencephalopathies. Here we provide an overview of the clinical and genetic features of these disorders in adults.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Leucoencefalopatias / Exoma Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / Leucoencefalopatias / Exoma Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article